289 related articles for article (PubMed ID: 23786294)
1. Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.
Skyler JS; Pugliese A
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2(Suppl 2):S2-13-S2-20. PubMed ID: 23786294
[TBL] [Abstract][Full Text] [Related]
2. Targeting the trimolecular complex: the pathway towards type 1 diabetes prevention.
Michels AW
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2(Suppl 2):S2-8-S2-12. PubMed ID: 23786298
[TBL] [Abstract][Full Text] [Related]
3. Prevention versus intervention of type 1 diabetes.
Brooks-Worrell B; Palmer JP
Clin Immunol; 2013 Dec; 149(3):332-8. PubMed ID: 23803322
[TBL] [Abstract][Full Text] [Related]
4. Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.
Simmons K; Michels AW
Rheum Dis Clin North Am; 2014 Nov; 40(4):797-811. PubMed ID: 25437293
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
6. Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.
Hampe CS
Autoimmunity; 2012 Jun; 45(4):320-31. PubMed ID: 22288464
[TBL] [Abstract][Full Text] [Related]
7. Immune therapy and β-cell death in type 1 diabetes.
Lebastchi J; Deng S; Lebastchi AH; Beshar I; Gitelman S; Willi S; Gottlieb P; Akirav EM; Bluestone JA; Herold KC
Diabetes; 2013 May; 62(5):1676-80. PubMed ID: 23423576
[TBL] [Abstract][Full Text] [Related]
8. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.
Gill RG; Pagni PP; Kupfer T; Wasserfall CH; Deng S; Posgai A; Manenkova Y; Bel Hani A; Straub L; Bernstein P; Atkinson MA; Herold KC; von Herrath M; Staeva T; Ehlers MR; Nepom GT
Diabetes; 2016 May; 65(5):1310-6. PubMed ID: 26718498
[TBL] [Abstract][Full Text] [Related]
9. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
[TBL] [Abstract][Full Text] [Related]
10. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
Yu L; Cuthbertson DD; Maclaren N; Jackson R; Palmer JP; Orban T; Eisenbarth GS; Krischer JP;
Diabetes; 2001 Aug; 50(8):1735-40. PubMed ID: 11473032
[TBL] [Abstract][Full Text] [Related]
11. Trials in type 1 diabetes: Antigen-specific therapies.
Coppieters KT; Harrison LC; von Herrath MG
Clin Immunol; 2013 Dec; 149(3):345-55. PubMed ID: 23490422
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease.
Jaberi-Douraki M; Liu SW; Pietropaolo M; Khadra A
Pediatr Diabetes; 2014 May; 15(3):162-74. PubMed ID: 24827702
[TBL] [Abstract][Full Text] [Related]
13. Making progress: preserving beta cells in type 1 diabetes.
Gallagher MP; Goland RS; Greenbaum CJ
Ann N Y Acad Sci; 2011 Dec; 1243():119-34. PubMed ID: 22211897
[TBL] [Abstract][Full Text] [Related]
14. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
15. [One step towards restoration of self-tolerance in human autoimmune diseases].
Chatenoud L
Med Sci (Paris); 2007 Feb; 23(2):167-71. PubMed ID: 17291426
[TBL] [Abstract][Full Text] [Related]
16. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
17. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
18. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.
Pietropaolo M; Towns R; Eisenbarth GS
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028135
[TBL] [Abstract][Full Text] [Related]
19. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
[TBL] [Abstract][Full Text] [Related]
20. Clinical and experimental treatment of type 1 diabetes.
Long SA; Buckner JH
Clin Exp Immunol; 2022 Dec; 210(2):105-113. PubMed ID: 35980300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
